{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:04:21Z","timestamp":1768745061984,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI17\/313"],"award-info":[{"award-number":["FIS PI17\/313"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00428-022-03372-x","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T04:02:30Z","timestamp":1656907350000},"page":"967-973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PCM1::JAK2 fusion associates with an atypical form of mycosis fungoides"],"prefix":"10.1007","volume":"481","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4741-7925","authenticated-orcid":false,"given":"Juan Jose","family":"Rodriguez-Sevilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-5977","authenticated-orcid":false,"given":"Marta","family":"Salido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Rodriguez-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Sanchez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-3828","authenticated-orcid":false,"given":"Fernando","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-6055","authenticated-orcid":false,"given":"Ramon Maria","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5236-5085","authenticated-orcid":false,"given":"Luis","family":"Colomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"3372_CR1","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3324\/haematol.2012.080754","volume":"97","author":"J Schwaller","year":"2012","unstructured":"Schwaller J (2012) Modeling ETV6-JAK2-induced leukemia: insights from the zebrafish. Haematologica 97:1783\u20131785. https:\/\/doi.org\/10.3324\/haematol.2012.080754","journal-title":"Haematologica"},{"key":"3372_CR2","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1182\/blood-2010-06-291310","volume":"117","author":"K Van Roosbroeck","year":"2011","unstructured":"Van Roosbroeck K, Cox L, Tousseyn T, Lahortiga I, Gielen O, Cauwelier B et al (2011) JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma. Blood 117:4056\u20134064. https:\/\/doi.org\/10.1182\/blood-2010-06-291310","journal-title":"Blood"},{"key":"3372_CR3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/gcc.20585","volume":"47","author":"JL Poitras","year":"2008","unstructured":"Poitras JL, Dal Cin P, Aster JC, Deangelo DJ, Morton CC (2008) Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia. Genes Chromosom Cancer 47:884\u2013889. https:\/\/doi.org\/10.1002\/gcc.20585","journal-title":"Genes Chromosom Cancer"},{"key":"3372_CR4","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.3324\/haematol.2015.132837","volume":"100","author":"C P\u00e9rez","year":"2015","unstructured":"P\u00e9rez C, Gonz\u00e1lez-Rinc\u00f3n J, Onaindia A, Almar\u00e1z C, Garc\u00eda-D\u00edaz N, Pisonero H et al (2015) Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma. Haematologica 100:e450\u2013e453. https:\/\/doi.org\/10.3324\/haematol.2015.132837","journal-title":"Haematologica"},{"key":"3372_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ng.3356","volume":"47","author":"J Choi","year":"2015","unstructured":"Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K et al (2015) Genomic landscape of cutaneous T cell lymphoma. Nat Genet 47:1011\u20131019. https:\/\/doi.org\/10.1038\/ng.3356","journal-title":"Nat Genet"},{"key":"3372_CR6","unstructured":"Swerdlow SH, Campo E, Harris NL, et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon."},{"key":"3372_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/nejm199204233261704","volume":"326","author":"TH Davis","year":"1992","unstructured":"Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME (1992) Hodgkin\u2019s disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115\u20131122. https:\/\/doi.org\/10.1056\/nejm199204233261704","journal-title":"N Engl J Med"},{"key":"3372_CR8","doi-asserted-by":"publisher","unstructured":"Riedlinger GM, Chojecki A, Aviv H, Weissmann D, Joshi S, Murphy SM, et al (2019) Hodgkin lymphoma and cutaneous T-cell lymphoma sharing the PCM1-JAK2 fusion and a common T-cell clone. JCO Precis Oncol 1-8. https:\/\/doi.org\/10.1200\/po.19.00082","DOI":"10.1200\/po.19.00082"},{"key":"3372_CR9","doi-asserted-by":"publisher","unstructured":"Fernandez-Pol S, Neishaboori N, Chapman CM, Khodadoust MS, Kim YH, Rieger KE, et al (2021) Two cases of mycosis fungoides with PCM1-JAK2 fusion. JCO Precis Oncol 646-652. https:\/\/doi.org\/10.1200\/po.20.00366","DOI":"10.1200\/po.20.00366"},{"key":"3372_CR10","doi-asserted-by":"publisher","unstructured":"Bastidas Torres AN, Cats D, Out-Luiting JJ, Fanoni D, Mei H, Venegoni L, et al (2021) Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2020.274506","DOI":"10.3324\/haematol.2020.274506"},{"key":"3372_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/PAS.0000000000001708","volume":"45","author":"MJ Fitzpatrick","year":"2021","unstructured":"Fitzpatrick MJ, Massoth LR, Marcus C, Vergilio JA, Severson E, Duncan D et al (2021) JAK2 rearrangements are a recurrent alteration in CD30+ systemic T-cell lymphomas with anaplastic morphology. Am J Surg Pathol 45:895\u2013904. https:\/\/doi.org\/10.1097\/PAS.0000000000001708","journal-title":"Am J Surg Pathol"},{"key":"3372_CR12","doi-asserted-by":"publisher","first-page":"103775","DOI":"10.18632\/oncotarget.21790","volume":"8","author":"I Panagopoulos","year":"2017","unstructured":"Panagopoulos I, Gorunova L, Spetalen S, Bassarova A, Beiske K, Micci F et al (2017) Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma. Oncotarget 8:103775\u2013103784. https:\/\/doi.org\/10.18632\/oncotarget.21790","journal-title":"Oncotarget"},{"key":"3372_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1023\/a:1023805715476","volume":"22","author":"A Verma","year":"2003","unstructured":"Verma A, Kambhampati S, Parmar S, Platanias LC (2003) Jak family of kinases in cancer. Cancer Metastasis Rev 22:423\u2013434. https:\/\/doi.org\/10.1023\/a:1023805715476","journal-title":"Cancer Metastasis Reviews"},{"key":"3372_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/s1097-2765(00)00067-8","volume":"6","author":"J Schwaller","year":"2000","unstructured":"Schwaller J, Parganas E, Wang D, Cain D, Aster JC, Williams IR et al (2000) Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL\/JAK2. Mol Cell 6:693\u2013704. https:\/\/doi.org\/10.1016\/s1097-2765(00)00067-8","journal-title":"Mol Cell"},{"key":"3372_CR15","doi-asserted-by":"publisher","first-page":"e53767","DOI":"10.1371\/journal.pone.0053767","volume":"8","author":"S Ehrentraut","year":"2013","unstructured":"Ehrentraut S, Nagel S, Scherr ME, Schneider B, Quentmeier H, Geffers R et al (2013) t(8;9)(p22;p24)\/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5. PLoS One 8:e53767. https:\/\/doi.org\/10.1371\/journal.pone.0053767","journal-title":"PLoS ONE"},{"key":"3372_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3324\/haematol.2012.067959","volume":"98","author":"A Chase","year":"2013","unstructured":"Chase A, Bryant C, Score J, Haferlach C, Grossmann V, Schwaab J et al (2013) Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements. Haematologica 98:404\u2013408. https:\/\/doi.org\/10.3324\/haematol.2012.067959","journal-title":"Haematologica"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03372-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03372-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03372-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T05:09:22Z","timestamp":1670562562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03372-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3372"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03372-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"23 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}